Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2019 / Article

Erratum | Open Access

Volume 2019 |Article ID 3084083 | 3 pages | https://doi.org/10.1155/2019/3084083

Erratum to “Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway”

Received09 May 2019
Accepted16 May 2019
Published10 Sep 2019

In the article titled “Ginkgo Biloba Leaf Extract Attenuates Atherosclerosis in Streptozotocin-Induced Diabetic ApoE-/- Mice by Inhibiting Endoplasmic Reticulum Stress via Restoration of Autophagy through the mTOR Signaling Pathway” [1], there was an error in the group labels of Figures 5(d) and 5(e), where the second and third group labels in each image were reversed. Additionally, there was an error in Figure 5(b) where the symbol “” should be corrected to “” in the Normal group bar. The corrected figure is shown below.

References

  1. J. Tian, M. S. Popal, Y. Liu et al., “Ginkgo biloba leaf extract attenuates atherosclerosis in streptozotocin-induced diabetic ApoE-/- mice by inhibiting endoplasmic reticulum stress via restoration of autophagy through the mTOR signaling pathway,” Oxidative Medicine and Cellular Longevity, vol. 2019, Article ID 8134678, 19 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2019 Jinfan Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

464 Views | 193 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.